Description
The ICA Screen ELISA Assay Kit system uses the ability of IC autoantibodies to act di-valently, that is, to form a bridge between autoAntigenss (highly purified material from primate source) coated onto the plate and liquid phase autoAntigens-Biotin. In the first step IC autoantibodies from the sample bind to autoAntigenss coated on the microtiter plate. In a second step IC-autoAntigens-Biotin binds to this complex which correlates with the amount of IC autoantibodies in patient’s serum. Unbound IC-autoAntigens-Biotin is removed by washing